Terveystaloustieteen tapahtumat & tiedonjulkistamisen valtionpalkinnon äänestys

Tiedoksenne seuraavat terveystaloustieteen tapahtumat ja tiedonjulkistamisen valtionpalkinnon äänestys:

1. EuHEA Conference 2024 in Vienna – Call for Abstracts DL 21.1.2024

2. EuHEA Online Seminar Series Fall 2023: Next seminar, 7 November 2023

3. Kenelle Tiedonjulkistamisen valtionpalkinto 2024? Ehdota oivaltavaa ja ajankohtaista tietokirjaa tai muuta DL 1.12.2023

Tarkemmat tiedot tapahtumista löydät alta

**************************************************************

1. EuHEA Conference 2024 in Vienna – Call for Abstracts DL 21.1.2024

Dear Colleagues,

We are excited to inform you that the Call for Abstracts for the upcoming EuHEA Conference, to be held in Vienna, Austria, from 30th June to 3rd July 2024, is now open. The theme of the conference is ‘Opening up perspectives on health economics’ and submissions from all areas of health economics are welcome.

We are very pleased also to announce that Carol Propper (Imperial College London) and Owen O’Donnell (Erasmus University Rotterdam) will join the EuHEA Conference 2024 as keynote speakers.

Please submit your abstract or organised session via this link by latest 21st January 2024. Kindly ensure that your abstract does not exceed 2,800 characters and includes objectives, methods, results, and discussion. We look forward to receiving your submission.

For more information regarding the conference program, the pre-conference workshops, and hotel reservations please visit the conference website.

The conference will be hosted by the Vienna University of Economics and Business (WU) and the Institute for Advanced Studies (IHS), supported by the Austrian Public Health Institute (Gesundheit Österreich GmbH).

We are looking forward to welcoming you at the EuHEA Conference 2024 in Vienna.

---------------------------------------------------------------------------------------------

2. EuHEA Online Seminar Series Fall 2023: Next seminar, 7 November 2023

The European Health Economics Association Seminar Series, established as a key activity of EuHEA to foster exchange between health economists across countries and institutions and present cutting-edge research in all areas of health economics.

Seminars are held online and will take place on Tuesdays, 1:30-2:30pm (CET time).

For more details on the seminar series: EuHEA Seminar Series Fall 2023 (Note the times are CET - Central European Time)

This is the zoom link to access them on the day.  The link is always the same.  It is also on the website above.

Next Seminar:

7 November 2023, 1:30-2:30 (CET)

Multimarket competition and pharmaceutical firms’ exit decision

Objectives: Multimarket contacts (MMC), which correspond to firms’ overlap across markets, may facilitate tacit collusion and thus reduce the intensity of competition. While there is extensive evidence that MMC decrease within-market competition, this study aims to evaluate whether multimarket contacts also influence market participation decisions, in the Portuguese off-patent drug market.

Methods: Resorting to a simple theoretical model of multimarket competition, it is shown that the potential of MMC to enhance collusion may depend on the ability of these contacts to restore an overall symmetry between companies which may fail to be observed in individual markets. As existing empirical MMCmeasures fail to account for this, this paper puts forward a theory-founded measure which weights contacts between companies by their importance in smoothing market share asymmetries. Based on the proposed theory-founded MMC measure, the paper tests whether pharmaceutical firms with greater MMC have greater survival chances in individual markets. The monthly dataset, ranging from January 2018 until December 2021, comprised on average 199 companies and 260 markets.

Results: Based on linear probability models with fixed effects and conditional logit models, it is shown that when the unit of analysis is the firm-in-market (i.e., a firm in a given market) higher MMC with competitors do not influence pharmaceutical firms’ survival chances in individual markets. Nonetheless, when the unit of analysis is a market, higher average MMC between companies active in a market are associated with a lower probability of observing firms’ exit from that market. Indeed, if MMC in a given market increase by one unit, then the probability of observing at least one firm exit the market over the course of one year decreases by 1.14 percentage points. These distinct results suggest that the degree of mutual forbearance is essentially a feature of the individual market under consideration, and not a characteristic of inter-firm rivalry independent of the level of competition faced by other competitors in the market.

Conclusions: While cost savings in the retail prescription drug market crucially depend on competition from generic drug producers, the results from this study suggest that these savings may be lower than expected due to the mutual forbearance incentive that MMC create. The finding that greater multimarket connections between companies soften competition and, consequently, decrease firms’ exit rates gives strength to the argument that drug prices (even off-patent drug prices) need to be regulated through price caps. Indeed, direct price regulation counters the incentive that multimarket competitors have to attenuate competition.

Speaker: Carolina Santos, Nova School of Business and Economics

Discussant: George Siotis, Universidad Carlos III de Madrid

Chair: Céu Mateus, Lancaster University

Future dates for your diary (all 1:30-2:30 CET):

14 November 2023, 1:30-2:30pm (CET)

The Electoral Returns to Investing in Healthcare

Speaker: Marcela dos Santos, University of Pittsburgh

Discussant: Mariana Lopes da Fonseca, University of St. Gallen

Chair: Pedro Pita Barros, NOVA School of Business and Economics

21 November 2023, 1:30-2:30pm (CET)

Are the grandparents alright? The health consequences of grandparental childcare provision

Speaker: Emma Zai, Max Planck Institute for Demographic Research

Discussant: Judith Bom, Erasmus School of Health Policy and Management

Chair: Bruce Hollingsworth, Lancaster University

28 November 2023, 1:30-2:30pm (CET)

A Systematic Review of Equity Issues Experienced by Older Adults with Rare Diseases

Speaker: Jean Pierre Uwitonze, University of Bern

Discussant: Joachim Marti, University of Lausanne

Chair: Céu Mateus, Lancaster University

5 December 2023, 1:30-2:30pm (CET)

Provider and patient delay: Income, utilisation, and multimorbidity predict health care accessibility in Austria, the UK and the USA during the COVID-19 pandemic

Speaker: Thomas Resch, Medical University of Vienna

Discussant: Carolina Santos, Nova School of Business and Economics

Chair: Bruce Hollingsworth, Lancaster University

12 December 2023, 1:30-2:30pm (CET)

Can interventions help reduce diabetes incidence? Evidence from NHS DPP participation

Speaker: Vasudha Wattal, Manchester University

Discussant: tbd

Chair: Pedro Pita Barros, NOVA School of Business and Economics

19 December 2023, 1:30-2:30pm (CET)

The role of physician altruism in the physician-industry relationship: Evidence from combining experimental and observational data

Speaker: Shan Huang, University of Zurich

Discussant: Odd Rune Straume, University of Minho

Chair: Céu Mateus, Lancaster University

*************************************************************

3. Kenelle Tiedonjulkistamisen valtionpalkinto 2024? Ehdota oivaltavaa ja ajankohtaista tietokirjaa tai muuta tiedeviestinnän tekoa

Tiedonjulkistamisen valtionpalkinto myönnetään merkittävästä ja ajankohtaisesta tiedonjulkistamistyöstä, joka on lisännyt kansalaisten tietämystä ja antanut virikkeitä yhteiskunnalliselle keskustelulle.

Mikä tietokirja innosti ja tarjosi uusia näkökulmia vuonna 2023? Kuka tai mikä yhteisö viesti tutkitusta tiedosta ymmärrettävästi ja selkeästi? Törmäsitkö tahoon tai tekoon, jossa luotettavaa tutkittua tietoa julkaistiin ja välitettiin tuoreella tavalla suurelle yleisölle?  

Kerro meille ansioituneista ja ajankohtaisista tiedonjulkistamisen teoista, jotka ovat vuonna 2023 herättäneet yhteiskunnallista keskustelua ja tarjonneet oivalluksen hetkiä tiedon parissa. Ehdotuksia voivat tehdä sekä yksityiset henkilöt että yhteisöt. Ehdota Tiedonjulkistamisen valtionpalkintoa 2024 verkkosivuillamme 1.12. mennessä. 

Opetus- ja kulttuuriministeriö myöntää vuosittain tiedonjulkistamisen valtionpalkinnot Tiedonjulkistamisen neuvottelukunnan (TJNK) esityksestä. Palkinto myönnetään ajankohtaisesta ja ansioituneesta tiedonjulkistamistyöstä, jonka muoto voi olla esimerkiksi tietokirja, journalistinen teko, dokumentti, tapahtuma tai esitys. Kaikkien julkaisumuotojen kohdalla palkittuja yhdistää se, että luotettavaa tutkittua tietoa on välitetty ymmärrettävästi, innostavasti, vastuullisesti ja monimuotoisesti suurelle yleisölle. Tietoa voidaan julkistaa myös taiteen keinoin.  

Lue lisää valtionpalkinnoista ja ehdotuksen tekemisestä. Otamme samalla vastaan ehdotuksia tietokirjoista vähälevikkisen laatukirjallisuuden ostotukilistalle. Lue lisää täältä.  

Tutustu vuoden 2023 tiedonjulkistamisen valtionpalkittuihin tästä.  

Tiedonjulkistamisen valtionpalkinnoilla edistetään luotettavan tutkitun tiedon saatavuutta, joka on sekä ihmisoikeus että toimivan demokratian edellytys. Tutkittu tieto kuuluu kaikille.